À¯·´ÀÇ ÁÖÀÔ ¿ä¹ý ½ÃÀå : ±Ô¸ð, Á¡À¯À², COVID-19ÀÇ ¿µÇ⠺м®(2023-2029³â) - MedSuite
Infusion Therapy Market Size, Share & COVID19 Impact Analysis | Europe | 2023-2029 | MedSuite | Includes: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks & Blood Transfusion Sets
»óǰÄÚµå : 1328964
¸®¼­Ä¡»ç : iData Research Inc.
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 695 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 8,995 £Ü 12,541,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 9,995 £Ü 13,936,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,995 £Ü 15,330,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(ÇØ¿Ü)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

2022³â À¯·´ÀÇ ÁÖÀÔ ¿ä¹ý ½ÃÀå ±Ô¸ð´Â 11¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ¿¹Ãø ±â°£ Áß »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµÇ¸ç 2029³â¿¡´Â ÃÖ¼Ò 13¾ï À¯·Î ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯·´ÀÇ ³ëÀÎ Àα¸ Áõ°¡´Â ÁÖÀÔ ¿ä¹ý ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. °í·ÉÈ­·Î ÀÎÇØ ºó¹øÇÏ°í ¸¸¼ºÀûÀÎ Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϸ鼭 ÁÖÀÔ ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÀÏȸ¿ë ±â±â ½ÃÀå°ú ijÇÇÅ» ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ°í ¿¹Ãø ±â°£ Áß ÆÇ¸Å·® Áõ°¡¸¦ °¡Á®¿Ã °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¸¼º Ä¡·á ÇöÀå¿¡¼­ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Áö³­ 5³â µ¿¾È À¯·´ ±¹°¡¿¡¼­´Â ´Ïµé¸®½º Ä¿³ØÅÍÀÇ ±Þ¼ÓÇÑ ½ÃÀå µµÀÔ Ãß¼¼°¡ µÎµå·¯Á³½À´Ï´Ù. ÀÌ·¯ÇÑ °ü½É Áõ°¡´Â ÀÌ·¯ÇÑ Ä¿³ØÅͰ¡ Á¦°øÇÏ´Â ¿©·¯ °¡Áö ÀåÁ¡¿¡ ±âÀÎÇÕ´Ï´Ù. °¡Àå Å« ÀåÁ¡ Áß Çϳª´Â ¹Ù´Ã¿¡ Âñ¸®´Â ¼Õ»ó ¹× °ü·Ã °¨¿°ÀÇ À§ÇèÀ» ÁÙ¿© ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½ÃŲ´Ù´Â Á¡ÀÔ´Ï´Ù. ¶ÇÇÑ ´Ïµé¸®½º Ä¿³ØÅÍ´Â ¾à¹°¿¡ ´ëÇÑ Á¢±Ù°ú Åõ¿©¸¦ ¿ëÀÌÇÏ°Ô ÇÏ°í ¿©·¯ ¹ø ¹Ù´ÃÀ» Âñ·¯¾ß ÇÒ Çʿ伺À» ÁÙÀÓÀ¸·Î½á ÆíÀǼº°ú È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡Àº À¯·´ Àü¿ª¿¡¼­ ´Ïµé¸®½º Ä¿³ØÅÍÀÇ º¸±ÞÀ» ÃËÁøÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

2022³â, B.BraunÀº À¯·´ ÁÖÀÔ ¿ä¹ý ½ÃÀå¿¡¼­ ¼±µÎ·Î µµ¾àÇß½À´Ï´Ù. ÀÌ È¸»ç´Â ¼ö¾× ¼¼Æ®¿Í ¼ö¾× ÆßÇÁ ½ÃÀå¿¡¼­ Å« ¸ÅÃâÀ» ´Þ¼ºÇßÀ¸¸ç, µ¿½Ã¿¡ ½ºÅéÄÛ ½ÃÀå¿¡¼­µµ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ½À´Ï´Ù. Á¾ÇÕÀûÀÎ ÁÖÀÔ ¿ä¹ý Á¦Ç°À» Á¦°øÇÏ°í ´Ù¾çÇÑ ¼ÒºñÀÚ ¿ä±¸¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â B. ºê¶ó¿îÀÇ ´É·ÂÀº Becton DickinsonÀÌ 2022³â À¯·´ ÁÖÀÔ ¿ä¹ý ½ÃÀå¿¡¼­ ÁÖ¿ä °æÀï»ç Áß 2À§¸¦ Â÷ÁöÇÒ ¼ö ÀÖ´Â °­·ÂÇÑ À§Ä¡¸¦ È®º¸Çß½À´Ï´Ù. Fresenius Kabi´Â À¯·´ ÁÖÀÔ ¿ä¹ý ½ÃÀåÀÇ »óÀ§ °æÀï»ç Áß 3À§¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ È¸»ç´Â Á¦Á¶ ºñ¿ë Àý°¨À¸·Î º´¿ø°ú ±×·ì ±¸¸Å Á¶Á÷(GPO)ÀÌ Àú·ÅÇÑ °¡°ÝÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» ÀÌ·èÇß½À´Ï´Ù.

À¯·´ÀÇ ÁÖÀÔ ¿ä¹ý ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ºÎ¹®º° µ¿Çâ, COVID-19ÀÇ ¿µÇ⠺м®, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, °æÀï»ç ½ÃÀå Á¡À¯À² ºÐ¼®, ½ÃÀå ÁøÃâ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

À¯·´ÀÇ ÁÖÀÔ ¿ä¹ý ½ÃÀå °³¿ä

Á¶»ç ¹æ¹ý

À¯·´ÀÇ ÁÖÀÔ ¿ä¹ý ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Áúº´ÀÇ °³¿ä

Á¦Ç° Æò°¡

À¯·´ÀÇ ÁÖÀÔ ¿ä¹ý ½ÃÀå °³¿ä

±¹°¡ °³¿ä

ÁÖÀÔ ÆßÇÁ ½ÃÀå

Á¤¸ÆÁÖ»ç ¼¼Æ® ½ÃÀå

´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå

ȰÀü ½ÃÀå

Á¤¸Æ³» ÇÊÅÍ ½ÃÀå

¼öÇ÷ ±â±â ½ÃÀå

¾à¾î

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

In 2022, the European market for infusion therapy devices achieved a valuation of $1.1 billion. Over the forecast period, it is expected to experience significant growth, reaching a value of at least €1.3 billion by 2029.

This medical market research involved a thorough analysis of 46 infusion therapy companies operating across Europe. Through our comprehensive methodology, we obtained insights into market sizes, unit sales, company market shares, and created accurate forecasts.

The full report suite on the European market for infusion therapy devices comprises six categories: infusion pumps, intravenous (IV) sets, needleless connectors (NLCs), IV filters, stopcocks, and blood transfusion sets. Each category is further segmented based on specific distinguishing factors. The infusion pump market is segmented by the type of infusion performed, including large-volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, electronic ambulatory pumps, and disposable ambulatory pumps. Each pump sub-segment is also further segmented by care setting. The IV set market is segmented based on tubing type, such as pump IV sets, gravity IV sets, secondary IV sets, and IV extension sets. Each type of IV set is also segmented by care setting. The needleless connector market is segmented by displacement type, including negative, positive, neutral, and anti-reflux neutral displacement connectors. Additionally, it is segmented by device type (standalone and integrated) and care setting.

DATA TYPES INCLUDED:

INFUSION THERAPY MARKET INSIGHT

The growing elderly population in Europe is a major driver for the infusion therapy device market. With the aging population, there is an increased need for frequent and chronic treatments, leading to a rise in demand for infusion therapy devices. This trend is expected to fuel the growth of both the disposable and capital equipment markets, resulting in an increase in unit sales during the forecast period. The growing need for these devices in chronic treatment settings further contributes to the market's expansion.

Over the past five years, European countries have shown a significant trend towards rapid adoption of needleless connectors in the market. This growing interest can be attributed to the numerous advantages offered by these connectors. One key benefit is the improved patient safety they provide by reducing the risk of needlestick injuries and associated infections. Additionally, needleless connectors enhance convenience and efficiency by enabling easier access and administration of medications, thus reducing the need for multiple needle insertions. These advantages have played a pivotal role in driving the widespread adoption of needleless connectors across Europe.

INFUSION THERAPY MARKET SHARE INSIGHT

In 2022, B. Braun emerged as the leading competitor in the European infusion therapy device market. The company achieved significant revenues in the IV set and infusion pump markets, while also leading the market for stopcocks. B. Braun's ability to offer a comprehensive range of infusion therapy products and cater to diverse consumer needs has contributed to its strong market position. Becton Dickinson secured the second position as a leading competitor in the European infusion therapy device market in 2022. The company was involved in various segments of the market covered in this report and demonstrated particular strength in the needleless connector market. Fresenius Kabi ranked third among the top competitors in the European infusion therapy device market. The company has experienced notable growth attributed to its lower manufacturing costs, enabling hospitals and group purchasing organizations (GPOs) to benefit from lower prices.

RESEARCH REGIONAL COVERAGE

Throughout this research series, iData Research has covered several countries in great detail. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Scandinavia (Norway, Finland, Sweden, and Denmark)
  • Switzerland
  • Austria
  • Portugal

SEGMENTS COVERED:

Feel free to click on each title to view detailed market segmentation. Please note that the analysis of each of the Infusion Therapy market segments can be purchased as separate reports, MedCores.

Infusion Pump Market - MedCore - The market analysis is further broken down by:

Intravenous Set Market - MedCore - The market is comprised of the segments broken down by:

Needleless Connector Market - MedCore - The market is further segmented by:

Table of Contents

Executive summary

European Infusion Therapy Device Market Overview

Research methodology

impact of covid-19 on THE European iNFUSION THERAPY DEVICE Market

Disease Overview

Product Assessment

European Infusion Therapy DEVICE Market Overview

Country Profiles

Infusion pump Market

Intravenous Set Market

Needleless Connector Market

Stopcock Market

IntraVenous Filter Market

Blood Transfusion Device Market

Abbreviations

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â